Explore All Access
Check if your research matches the topics covered in Antibody Therapeutics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Antibody Therapeutics : Impact Factor & More
eISSN: 2516-4236
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Antibody Therapeutics Key Metrics
CiteScore 
5
SJR
Q3Immunology
Topics Covered on Antibody Therapeutics
Antibody Therapeutics Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Oxford University Press |
| Language | English |
| Article Processing Charges | GBP 1750 | USD 2625 |
| Publication Time | 8 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Antibody Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Antibody Therapeutics
Antibody–drug conjugates in cancer and beyond: progress, promise, and perspectives
- 11 Jun 2025
- Antibody Therapeutics
A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy
- 22 May 2025
- Antibody Therapeutics
Matching placebo development for injectable biologics—a practical tutorial
- 8 May 2025
- Antibody Therapeutics
Bypassing the immunosuppressive effects of CA125/MUC16 via re-engineered rituximab (NAV-006) to improve its antitumor activity in vivo
- 24 Apr 2025
- Antibody Therapeutics
Preclinical development of mecbotamab vedotin (BA3011), a novel, AXL-specific conditional active biologic antibody–drug conjugate
- 28 Mar 2025
- Antibody Therapeutics
A review of conjugation technologies for antibody drug conjugates
- 28 Mar 2025
- Antibody Therapeutics
Antibody–drug conjugates in cancer and beyond: progress, promise, and perspectives
- 11 Jun 2025
- Antibody Therapeutics
A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy
- 22 May 2025
- Antibody Therapeutics
Matching placebo development for injectable biologics—a practical tutorial
- 8 May 2025
- Antibody Therapeutics
Bypassing the immunosuppressive effects of CA125/MUC16 via re-engineered rituximab (NAV-006) to improve its antitumor activity in vivo
- 24 Apr 2025
- Antibody Therapeutics
Preclinical development of mecbotamab vedotin (BA3011), a novel, AXL-specific conditional active biologic antibody–drug conjugate
- 28 Mar 2025
- Antibody Therapeutics
A review of conjugation technologies for antibody drug conjugates
- 28 Mar 2025
- Antibody Therapeutics
Compare Similar Journals with Antibody Therapeutics
Select Journals to Compare with Antibody Therapeutics
Total journals - 8
You can select up to 3 Journals at a time
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Scientific Reports
Publisher: NATURE PORTFOLIO
International Journal of Molecular Sciences
Publisher: MDPI
mAbs
Publisher: TAYLOR & FRANCIS INC
Antibodies
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Nature Communications
Publisher: NATURE PORTFOLIO
Journal for ImmunoTherapy of Cancer
Publisher: BMJ PUBLISHING GROUP
0 Journals Selected to compare with
Antibody Therapeutics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
